Open menu

The Regulatory Affairs Environment in Japan

Understand how to successfully navigate the Japanese health authorities and bring pharmaceutical products onto the Japanese market (module 4)

Download as PDF
Date icon
No available dates
Attendance icon

On location

Language icon

English

Price icon
17,650 DKK ex VAT

(app. 2,373 EUR ex VAT)

50% DISCOUNT FOR PUBLIC INSTITUTIONS
Home > Courses > The Regulatory Affairs Environment in Japan

Summary

This three day course will provide you with a thorough overview and in-depth case studies on how to successfully navigate the Japanese health authorities and bring pharmaceutical products onto the Japanese market. You will become familiar with the contents of drug dossiers, and the Japanese regulatory system, including the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labor and Welfare (MHLW). We will discuss the regulatory procedures throughout the drug development phases and how to successfully consult with PMDA, e.g., in the clinical trial notification phase.

You will get the latest trends in Japanese pharmaceutical regulations and procedures. You will receive lectures from senior Japanese regulatory professionals from industry, CROs and authorities.


    Keywords

    • Japanese pharmaceutical regulation
    • Japanese regulatory authorities
    • PMDA
    • Orphan Drug Designation (ODD) in Japan
    • Clinical trial notification, clinical studies and Good Clinical Practice (GCP) in Japan
    • Japanese new drug application
    • Chemical pharmaceutical documentation requirements (CMC)
    • Non-clinical and clinical documentation and requirements
    • Regulations for biologics and biotechnology products
    • Generic drug regulation in Japan
    • Pharmacovigilance
    • National Health Insurance (NHI) pricing
    • Patent and regulatory data protection

      Hi! 

      Do you need help choosing the right course? 

      We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com 

      Stay tuned with Atrium's newsletter 


    Save information for later
    Read more

    Course leader & lecturers

    • Malene Kjær Müller
      Course leader
      VP, R&D Portfolio & Program Leadership
      LEO Pharma A/S
    • Katja Gustafsson
      Course leader
      Senior Consultant
      Hansa Biopharma AB
    See all

    Watch the video

    Is this course for you?

    Whether you are new to the field or have several years of experience, this course is relevant if you are a Regulatory Affairs Professional who wants to improve your knowledge and skills

    What you will learn

    1. To understand the Japanese drug development and post-approval framework and regulatory procedure
    2. The do’s and don’ts of constructive interactions with Japanese colleagues and officials
    3. How to successfully navigate the PMDA consultations
    4. How to play an important role in any project team working on obtaining a marketing authorization in Japan

    What your company will get

    1. An employee who understands the Japanese drug development, post-approval framework and regulatory procedures
    2. A regulatory professional who can make recommendations on how to achieve project goals in the shortest possible development time
    3. A regulatory professional who is able to successfully navigate the PMDA consultations
    4. A regulatory professional who can play an important strategic role in project teams working on obtaining a marketing authorization in Japan

    Course information

    Literature

    Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.

    Please familiarize yourself with the mandatory readings before starting the course.

    The mandatory readings are also part of the examination syllabus.

    Prerequisites

    To enroll in this course, you must have a relevant educational background at bachelor level and, as a minimum, two years of experience in regulatory affairs, or other equivalent qualifications. We consider all applications upon registration.

    If you do not fulfill the requirements, you can still apply for the course if you have experience in the pharmaceutical/biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 10% of the positions on our course are filled by applicants who have no or limited experience in regulatory affairs. We consider applicants on a case-by-case basis.

    Examination

    The exam  is held online, usually 4-6 weeks after the course.

     You will receive a link with exam questions via your personal Atrium log-in.

     In order to participate in the exam, you must have attended the course.

    This course is a part of a diploma

    Diploma in Regulatory Affairs

    The regulatory affairs diploma gives you an understanding of the entire regulatory affairs platform of the medicinal lifecycle. All courses have been designed in collaboration with highly acclaimed experts that are on our regulatory affairs Advisory Board.

    Read more

    Course leaders

    Malene Kjær Müller
    VP, R&D Portfolio & Program Leadership
    LEO Pharma A/S
    Katja Gustafsson
    Senior Consultant
    Hansa Biopharma AB

    You may also be interested in these courses

    Want to know more or need help?

    Contact Educational Programme Leader Lone Rex at +45 20 62 11 46

    Send me a message
    Go to FAQ